These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 35384375)

  • 21. [Critical illness polyneuropathy and critical illness myopathy].
    Grimm A; Günther A; Witte OW; Axer H
    Med Klin Intensivmed Notfmed; 2012 Nov; 107(8):649-58; quiz 659. PubMed ID: 23104463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Critical illness polyneuropathy and myopathy in a rural area in Vietnam.
    Nguyen The L; Nguyen Huu C
    J Neurol Sci; 2015 Oct; 357(1-2):276-81. PubMed ID: 26276515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational study.
    Weber-Carstens S; Deja M; Koch S; Spranger J; Bubser F; Wernecke KD; Spies CD; Spuler S; Keh D
    Crit Care; 2010; 14(3):R119. PubMed ID: 20565863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurement of excitation-contraction coupling time in critical illness myopathy.
    Hirose B; Ikeda K; Yamamoto D; Tsuda E; Yamauchi R; Hozuki T; Masuda Y; Imai T
    Clin Neurophysiol; 2022 Mar; 135():30-36. PubMed ID: 35026538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and neurophysiological characterization of muscular weakness in severe COVID-19.
    Bax F; Lettieri C; Marini A; Pellitteri G; Surcinelli A; Valente M; Budai R; Patruno V; Gigli GL
    Neurol Sci; 2021 Jun; 42(6):2173-2178. PubMed ID: 33755815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Critical illness polyneuropathy and myopathy as neurological complications of sepsis].
    Kollmar R
    Nervenarzt; 2016 Mar; 87(3):236-45. PubMed ID: 26842898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interventions for preventing critical illness polyneuropathy and critical illness myopathy.
    Hermans G; De Jonghe B; Bruyninckx F; Van den Berghe G
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006832. PubMed ID: 19160304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Critical illness myopathy: further evidence from muscle-fiber excitability studies of an acquired channelopathy.
    Allen DC; Arunachalam R; Mills KR
    Muscle Nerve; 2008 Jan; 37(1):14-22. PubMed ID: 17763454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA-sequencing reveals altered skeletal muscle contraction, E3 ligases, autophagy, apoptosis, and chaperone expression in patients with critical illness myopathy.
    Llano-Diez M; Fury W; Okamoto H; Bai Y; Gromada J; Larsson L
    Skelet Muscle; 2019 Apr; 9(1):9. PubMed ID: 30992050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical Illness Neuropathy.
    Tankisi H; de Carvalho M; Z'Graggen WJ
    J Clin Neurophysiol; 2020 May; 37(3):205-207. PubMed ID: 32358246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19-Associated Critical Illness Myopathy with Direct Viral Effects.
    Dodig D; Tarnopolsky MA; Margeta M; Gordon K; Fritzler MJ; Lu JQ
    Ann Neurol; 2022 Apr; 91(4):568-574. PubMed ID: 35148013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Critical illness myopathy.
    Meherali SM; Parpio Y; Ali TS
    J Pak Med Assoc; 2010 Nov; 60(11):961-3. PubMed ID: 21375205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for critical illness polyneuromyopathy with single nerve conduction studies.
    Moss M; Yang M; Macht M; Sottile P; Gray L; McNulty M; Quan D
    Intensive Care Med; 2014 May; 40(5):683-90. PubMed ID: 24623137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Approach to critical illness polyneuropathy and myopathy.
    Pati S; Goodfellow JA; Iyadurai S; Hilton-Jones D
    Postgrad Med J; 2008 Jul; 84(993):354-60. PubMed ID: 18716014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurogenic vs. Myogenic Origin of Acquired Muscle Paralysis in Intensive Care Unit (ICU) Patients: Evaluation of Different Diagnostic Methods.
    Marrero HDJG; Stålberg EV; Cooray G; Corpeno Kalamgi R; Hedström Y; Bellander BM; Nennesmo I; Larsson L
    Diagnostics (Basel); 2020 Nov; 10(11):. PubMed ID: 33217953
    [No Abstract]   [Full Text] [Related]  

  • 36. Critical Illness Myopathy.
    Z'Graggen WJ; Tankisi H
    J Clin Neurophysiol; 2020 May; 37(3):200-204. PubMed ID: 32358245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective clinical study on the mechanisms underlying critical illness myopathy-A time-course approach.
    Cacciani N; Skärlén Å; Wen Y; Zhang X; Addinsall AB; Llano-Diez M; Li M; Gransberg L; Hedström Y; Bellander BM; Nelson D; Bergquist J; Larsson L
    J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2669-2682. PubMed ID: 36222215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Critical Illness Myopathy: Diagnostic Approach and Resulting Therapeutic Implications.
    Rodriguez B; Larsson L; Z'Graggen WJ
    Curr Treat Options Neurol; 2022; 24(4):173-182. PubMed ID: 35370393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ICU-acquired weakness.
    Schweickert WD; Hall J
    Chest; 2007 May; 131(5):1541-9. PubMed ID: 17494803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.